M. H. Gholami

发表

The long and short non-coding RNAs modulating EZH2 signaling in cancer

Yuzhuo Wang, F. Crea, M. Ashrafizadeh, 2022, Journal of Hematology & Oncology.

Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance

Yuzhuo Wang, M. Ashrafizadeh, A. Kumar, 2022, Expert opinion on drug delivery.

Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression.

Michael R Hamblin, N. Voelcker, M. Hamblin, 2021, Carbohydrate polymers.

The long and short non-coding RNAs modulating EZH2 signaling in cancer

Yuzhuo Wang, F. Crea, M. Ashrafizadeh, 2022, Journal of Hematology & Oncology.

Review Article: Ivermectin: An Effective Remedy Against Various Diseases: A Literature Review

M. H. Gholami, F. Hashemi, M. Entezari, 2022 .

Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention

Yuzhuo Wang, M. Ashrafizadeh, A. Kumar, 2022, Journal of experimental & clinical cancer research : CR.

Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance.

M. Ashrafizadeh, P. Kubatka, M. Najafi, 2021, Pharmacological research.

Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer

M. Ashrafizadeh, A. Kumar, A. Zarrabi, 2022, Journal of Hematology & Oncology.

Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

Michael R Hamblin, F. Tajik, M. Hamblin, 2022, Journal of cellular physiology.

AIE-featured tetraphenylethylene nanoarchitectures in biomedical application: Bioimaging, drug delivery and disease treatment

V. Thakur, M. Ashrafizadeh, K. Rangappa, 2021 .

Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy.

M. Ashrafizadeh, P. Makvandi, A. Zarrabi, 2021, Life sciences.

Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis.

K. Ahn, M. Ashrafizadeh, M. Najafi, 2021, Life sciences.

Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy

G. Sethi, M. Ashrafizadeh, A. Kumar, 2021, Cells.

MicroRNAs regulating SOX2 in cancer progression and therapy response

M. Ashrafizadeh, A. Zarrabi, H. Khan, 2021, Expert Reviews in Molecular Medicine.

EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects.

M. Ashrafizadeh, A. Zarrabi, M. Hashemi, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response

Yuzhuo Wang, D. Klionsky, F. Crea, 2022, Journal of experimental & clinical cancer research : CR.

Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation.

M. Ashrafizadeh, P. Makvandi, A. Zarrabi, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response

Yuzhuo Wang, D. Klionsky, F. Crea, 2022, Journal of Experimental & Clinical Cancer Research.

Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies.

M. Ashrafizadeh, A. Zarrabi, M. Hashemi, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation.

A. Zarrabi, M. Hashemi, Sepideh Mirzaei, 2022, Pathology, research and practice.

Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer.

G. Sethi, M. Ashrafizadeh, A. Zarrabi, 2021, Pharmacological research.

Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers

M. Ashrafizadeh, A. Kumar, A. Zarrabi, 2021, Biomolecules.

Exosome-mediated miR-200a delivery into TGF-β-treated AGS cells abolished epithelial-mesenchymal transition with normalization of ZEB1, vimentin and Snail1 expression.

M. Ashrafizadeh, K. Parivar, A. Zarrabi, 2023, Environmental research.

The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets.

M. Ashrafizadeh, A. Zarrabi, H. Khan, 2021, European journal of pharmacology.

Investigating how Interleukin 6 Serum Level, Blood Group Type, and Underlying Diseases are Associated in Patients Admitted to the COVID-19 Intensive Care Unit: A Retrospective Study

M. H. Gholami, K. Hushmandi, Rasoul Raesi, 2023, The Open Public Health Journal.

A Study of how the Serum Levels of Inflammatory Markers Correlate with Hemoglobin Oxygen Saturation Percentage and the Type of Respiratory Support Received by Covid-19 Patients Hospitalized in Intensive Care Units

M. H. Gholami, K. Hushmandi, Rasoul Raesi, 2024, The Open Public Health Journal.

The potential immunomodulatory effect of levamisole in humans and farm animals

Sepideh Mirzaei, M. H. Gholami, F. Hashemi, 2023, Journal of advanced veterinary and animal research.